Hercules Capital, Inc. (HTGC) - 2016 Form 10-K Summary
Business Context and Reporting Period
This report covers the fiscal year ended December 31, 2016. Hercules Capital, Inc. (formerly Hercules Technology Growth Capital, Inc.) is an internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on providing senior secured loans, primarily structured debt with warrants, to high-growth, venture capital-backed companies in technology, life sciences, and sustainable/renewable technology sectors. As of December 31, 2016, the company held 82,791,403 shares of common stock outstanding.
Key Financial Metrics
| Metric | 2016 | 2015 |
|---|---|---|
| Total Assets | $1,464.2 million | $1,334.8 million |
| Investments at Fair Value | $1,423.9 million | $1,200.6 million |
| Total Liabilities | $676.3 million | $617.6 million |
| Net Assets | $787.9 million | $717.1 million |
| Net Asset Value (NAV) per Share | $9.90 | $9.94 |
| Total Investment Income | $175.1 million | $157.1 million |
| Net Investment Income | $100.3 million | $73.5 million |
| Net Realized Gain | $4.6 million | $5.1 million |
| Net Unrealized Depreciation | ($36.2 million) | ($35.7 million) |
| Net Increase in Net Assets from Operations | $68.7 million | $42.9 million |
| Distributions Declared per Share | $1.24 | $1.24 |
| Weighted Average Investment Grade | 2.41 | 2.16 |
Material Changes vs. Prior Period
- Portfolio Growth: The investment portfolio grew by approximately 18.6% to $1.42 billion, driven by new fundings of $680.7 million. The debt portfolio increased to $1.33 billion.
- Income Increase: Net investment income rose 36.5% to $100.3 million, primarily due to portfolio growth and a one-time $8.0 million litigation settlement. Interest income increased to $158.7 million.
- Unrealized Depreciation: The company recorded $36.2 million in net unrealized depreciation, largely attributed to collateral-based impairments on debt investments ($50.0 million) and equity investments ($7.4 million), partially offset by reversals of prior impairments.
- Portfolio Quality: The weighted average investment grade declined from 2.16 to 2.41, reflecting a net increase in Grade 3 and Grade 4 loans due to underperformance or near-term funding requirements. Non-accrual loans decreased in fair value to $6.2 million.
- Debt Structure: The company issued an additional $144.6 million in 2024 Notes during 2016. The 2016 Convertible Notes were fully settled. The company announced an intention to redeem the remaining 2019 Notes in February 2017.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items: Net investment income included an $8.0 million gain from a litigation settlement. Net realized gains included $9.3 million from the sale of Box, Inc. investments. Net realized losses included a $6.2 million loss on the settlement of a debt investment in The Neat Company.
- Outlook: Management intends to distribute 100% of spillover earnings from 2016 in 2017. The company maintains a variable distribution policy targeting 90-100% of taxable income. The company has $59.7 million in unfunded commitments and $55.0 million in non-binding term sheets.
- Liquidity: As of December 31, 2016, available liquidity was $203.0 million, including $13.0 million in cash and $190.0 million in available borrowing capacity under credit facilities (Wells and Union Bank).
- Risks:
- Concentration: 73.4% of the portfolio is concentrated in five industries, with Drug Discovery & Development representing 29.7%.
- Leverage: The company operates with significant leverage. The asset coverage ratio was 265.0% (excluding SBA debentures) and 218.0% (including SBA debentures), well above the 200% regulatory minimum.
- Valuation Uncertainty: 97.3% of assets are Level 3 investments valued in good faith by the Board, creating uncertainty regarding fair value.
- Interest Rate Risk: 92.1% of loans are floating rate; rising rates could increase portfolio company default risk.
Key Facts for Investor Verification
- NAV vs. Market Price: Verify the current trading price of HTGC relative to the reported NAV of $9.90 to assess the discount/premium.
- Asset Coverage Ratio: Confirm the company maintains the required 200% asset coverage ratio to ensure continued ability to pay dividends and incur debt.
- Portfolio Grading Trends: Monitor the weighted average investment grade (currently 2.41) and the percentage of Grade 4 and 5 assets for signs of deteriorating credit quality.
- Debt Redemption: Verify the successful redemption of the 2019 Notes announced for February 24, 2017, and the impact on interest expense.
- Unfunded Commitments: Assess the company's ability to fund the $59.7 million in unfunded commitments using existing liquidity and cash flows.
- Realized vs. Unrealized Gains: Note that net income was significantly impacted by unrealized depreciation ($36.2M) despite positive net investment income ($100.3M).